주요우울증에서 스트레스, 염증반응, 신경조직발생

키워드

참고문헌 (84)

1. Heim C, "The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies", Biol Psychiatry, 49, pp.1023~1039 (2001)
2. Heim C, "The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders", Biol Psychiatry, 46, pp.1509~1522 (1999)
3. Schildkraut JJ, "The catecholamine hypothesis of affective disorders: a review of supporting evidence", Am J Psychiatry, 122, pp.509~522 (1965)
4. Duman RS, "A molecular and cellular theory of depression", Arch Gen Psychiatry, 54, pp.597~606 (1997)
5. Maes M, "The cytokine hypothesis of depression: inflammation, oxidative& nitrosative stress (IO & NS) and leaky gut as new targets foradjunctive treatments in depression", Neuro Endocrinol Lett, 29, pp.287~291 (2008)
6. Leonard BE, "The immune system, depression and the action of antidepressants", Prog Neuropsychopharmacol Biol Psychiatry, 25, pp.767~780 (2001)
7. Leonard BE, "The HPA and immune axes in stress: the involvement of the serotonergic system", Eur Psychiatry, 20(3), pp.S302~S306 (2005)
8. de Kloet ER, "Stress and the brain: from adaptation to disease", Nat Rev Neurosci, 6, pp.463~475 (2005)
9. Caspi A, "Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene", Science, 301, pp.386~389 (2003)
10. Castrén E, "Is mood chemistry", Nat Rev Neurosci, 6, pp.241~246 (2005)
11. Ressler KJ, "Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic", Nat Neurosci, 10, pp.1116~1124 (2007)
12. Swaab DF, "The stress system in the human brain in depression and neurodegeneration", Ageing Res Rev, 4, pp.141~194 (2005)
13. Austin MP, "Cognitive deficits in depression: possible implications for functional neuropathology", Br J Psychiatry, 178, pp.200~206 (2001)
14. Sheline YI, "3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity", Biol Psychiatry, 48, pp.791~800 (2000)
15. MacQueen GM, "Course of illness, hippocampal function, and hippocampal volume in major depression", Proc Natl Acad Sci USA, 100, pp.1387~1392 (2003)
16. Sapolsky RM, "Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders", Arch Gen Psychiatry, 57, pp.925~935 (2000)
17. Stockmeier CA, "Cellular changes in the postmortem hippocampus in major depression", Biol Psychiatry, 56, pp.640~650 (2004)
18. Lucassen PJ, "Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure", Am J Pathol, 158, pp.453~468 (2001)
19. Czéh B, "What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated", Eur Arch Psychiatry Clin Neurosci, 257, pp.250~260 (2007)
20. Eriksson PS, "Neurogenesis in the adult human hippocampus", Nat Med, 4, pp.1313~1317 (1998)
21. Cameron HA, "Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus", J Comp Neurol, 435, pp.406~417 (2001)
22. Kempermann G, "More hippocampal neurons in adult mice living in an enriched environment", Nature, 386, pp.493~495 (1997)
23. Gould E, "Neurogenesis in the neocortex of adult primates", Science, 286, pp.548~552 (1999)
24. Gould E, "Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress", Proc Natl Acad Sci USA, 95, pp.3168~3171 (1998)
25. Cameron HA, "Restoring production of hippocampal neurons in old age", Nat Neurosci, 2, pp.894~897 (1999)
26. Müller N, "Role of the cytokine network in the CNS and psychiatric disorders", Nervenarzt, 68, pp.11~20 (1997)
27. Licinio J, "The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection", Mol Psychiatry, 4, pp.317~327 (1999)
28. Maes M, "The monocyte-T-lymphocyte hypothesis of major depression", Psychoneuroendocrinology, 20, pp.111~116 (1995)
29. Connor TJ, "Depression, stress and immunological activation: the role of cytokines in depressive disorders", Life Sci, 62, pp.583~606 (1998)
30. Kim YK, "The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs", Mol Psychiatry, 7, pp.1107~1114 (2002)
31. Pollak Y, "Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment", Int J Neuropsychopharmacol, 5, pp.389~399 (2002)
32. Smith RS, "The macrophage theory of depression", Med Hypotheses, 35, pp.298~306 (1991)
33. Maes M, "Major depression and activation of the inflammatory response system", Adv Exp Med Biol, 461, pp.25~46 (1999)
34. 김용구, "CYTOKINE-SEROTONIN INTERACTION THROUGH IDO: A NEURODEGENERATION HYPOTHESIS OF DEPRESSION", MED HYPOTHESES, 61, pp.519~525
35. Meyers CA, "Mood and cognitive disorders in cancer patients receiving cytokine therapy", Adv Exp Med Biol, 461, pp.75~81 (1999)
36. Dantzer R, "Mechanisms of the behavioural effects of cytokines", Adv Exp Med Biol, 461, pp.83~105 (1999)
37. Leonard BE, "Changes in the immune system in depression and dementia: causal or co-incidental effects", Int J Dev Neurosci, 19, pp.305~312 (2001)
38. Kim YK, "Differences in cytokines between non-suicidal patients and suicidal patients in major depression", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.356~361 (2008)
39. Kim YK, "Cytokine imbalance in the pathophysiology of major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1044~1053 (2007)
40. 김용구, "Th1, Th2, and Th3 cytokine alterations in major depression", JOURNAL OF AFFECTIVE DISORDERS, 88, pp.167~173
41. 김용구, "The role of IL-12 and TGF-beta 1 in the pathophysiology of major depressive disorder", INTERNATIONAL IMMUNOPHARMACOLOGY, 6, pp.1298~1304
42. Leonard BE, "HPA and immune axes in stress: involvement of the serotonergic system", Neuroimmunomodulation, 13, pp.268~276 (2006)
43. Sapolsky R, "Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor", Science, 238, pp.522~524 (1987)
44. Berkenbosch F, "Corticotropin- releasing factor-producing neurons in the rat activated by interleukin-1", Science, 238, pp.524~526 (1987)
45. Maes M, "Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression", Psychiatry Res, 49, pp.11~27 (1993)
46. Guillemin GJ, "IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment", J Interferon Cytokine Res, 21, pp.1097~1101 (2001)
47. Sakash JB, "Cytokines induce indole amine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection", Infect Immun, 70, pp.3959~3961 (2002)
48. Neveu PJ, "Is there evidence for an effect of antidepressant drugs on immune function", Adv Exp Med Biol, 461, pp.267~281 (1999)
49. Maes M, "Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion", Neuropsychopharmacology, 20, pp.370~379 (1999)
50. Xia Z, "Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells", Immunopharmacology, 34, pp.27~37 (1996)
51. Suzuki E, "Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA bychronic treatment with various psychotropics in widespread area ofrat brain", Neurosci Lett, 215, pp.201~204 (1996)
52. Nabriski D, "Role of corticotropin-releasing factor in immunosuppression", Trans Assoc Am Physicians, 104, pp.238~247 (1991)
53. Miller AH, "Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression", Adv Exp Med Biol, 461, pp.107~116 (1999)
54. Kim YK, "The role of cytokine network in psychological stress", Acta Neuropsychiatrica, 15, pp.148~155 (2003)
55. Ekdahl CT, "Brain inflammation and adult neurogenesis: the dual role of microglia", Neuroscience, 158, pp.1021~1029 (2009)
56. Kaneko N, "Suppression of cell proliferation by interferon-alpha through interleukin- 1 production in adult rat dentate gyrus", Neuropsychopharmacology, 31, pp.2619~2626 (2006)
57. Iosif RE, "Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis", J Neurosci, 26, pp.9703~9712 (2006)
58. Koo JW, "IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress", Proc Natl Acad Sci USA, 105, pp.751~756 (2008)
59. Monje ML, "Inflammatory blockade restores adult hippocampal neurogenesis", Science, 302, pp.1760~1765 (2003)
60. Duman RS, "Depression: a case of neuronal life and death", Biol Psychiatry, 56, pp.140~145 (2004)
61. Malberg JE, "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus", J Neurosci, 20, pp.9104~9110 (2000)
62. Czéh B, "Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine", Proc Natl Acad Sci USA, 98, pp.12796~12801 (2001)
63. Oomen CA, "Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress", Eur J Neurosci, 26, pp.3395~3401 (2007)
64. Santarelli L, "Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants", Science, 301, pp.805~809 (2003)
65. Warner-Schmidt JL, "Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment", Hippocampus, 16, pp.239~249 (2006)
66. Sahay A, "Adult hippocampal neurogenesis in depression", Nat Neurosci, 10, pp.1110~1115 (2007)
67. Kempermann G, "The contribution of failing adult hippocampal neurogenesis to psychiatric disorders", Curr Opin Psychiatry, 21, pp.290~295 (2008)
68. Revest JM, "Adult hippocampal neurogenesis is involved in anxiety-related behaviors", Mol Psychiatry, 14, pp.959~967 (2009)
69. Thompson A, "Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence", Genes Brain Behav, 7(1), pp.28~42 (2008)
70. Reif A, "Neural stem cell proliferation is decreased in schizophrenia, but not in depression", Mol Psychiatry, 11, pp.514~522 (2006)
71. Boldrini M, "Antidepressants increase neural progenitor cells in the human hippocampus", Neuropsychopharmacology, 34, pp.2376~2389 (2009)
72. Surget A, "Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal", Biol Psychiatry, 64, pp.293~301 (2008)
73. Lanni C, "Depression and antidepressants: molecular and cellular aspects", Cell Mol Life Sci, 66, pp.2985~3008 (2009)
74. Thase ME, "The clinical, psychosocial, and pharmacoeconomic ramifications of remission", Am J Manag Care, 7, pp.S377~S385 (2001)
75. Duman RS, "Synaptic plasticity and mood disorders", Mol Psychiatry, 7(1), pp.S29~S34 (2002)
76. Pollak DD, "An animal model of a behavioral intervention for depression", Neuron, 60, pp.149~161 (2008)
77. Czéh B, "Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depression", Psychopharmacology, 180, pp.548~557 (2005)
78. Toda H, "The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation", J Neurosurg, 108, pp.132~138 (2008)
79. Revesz D, "Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation", Exp Neurol, 214, pp.259~265 (2008)
80. Maier SF, "Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock", Brain Res, 695, pp.279~282 (1995)
81. Mansbach RS, "Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist", Eur J Pharmacol, 323, pp.21~26 (1997)
82. 김용구, "Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression", NEUROIMMUNOMODULATION, 14, pp.65~71
83. Müller N, "The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine", Mol Psychiatry, 11, pp.680~684 (2006)
84. Bauer J, "Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression", Biol Psychiatry, 38, pp.611~621 (1995)

관련 논문AI추천